DNA

GINKGO BIOWORKS HOLDINGS INC

Healthcare | Small Cap

-$0.53

EPS Forecast

$39.53

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.53

Revenue Forecast:

$39.53

EPS Surprise Forecast:

$0.011

Revenue Surprise Forecast:

-$1

Post-release price volatility - Very high

Post-release Overnight Move:

±11.5%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

56%

Probability of beating revenue consensus:

46%

Probability of beating both EPS & revs consensus:

31%

Probability of missing both EPS & revs consensus:

30%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.20

Revenue standard deviation:

$7

As % of share price:

2.87% VERY HIGH

As % of market cap:

1.73% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.29

Revenue 95th %ile:

$48

EPS 75th %ile:

-$0.46

Revenue 75th %ile:

$42

EPS 25th %ile:

-$0.59

Revenue 25th %ile:

$38

EPS 5th %ile:

-$0.77

Revenue 5th %ile:

$32

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

37% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

61% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$50

Bid-ask per Share:

$0.035